Successful completion of USFDA inspection at Alembic Pharmaceuticals Limited’ Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav.
9th October, 2024, Bengaluru: Alembic Pharmaceuticals today announced that it has successfully completed the United States Food...